Anna Morales, Jason Candreva, Thilina Jayarathne, Abbie L Esterman, Sudhakar Voruganti, Shannon C Flagg, Thomas Slaney, Peiran Liu, Michael Adamo, Saileshkumar Patel, Tapan K Das, Ming Zeng, Xue Li
Identification (ID) testing is a regulatory requirement for biopharmaceutical manufacturing, requiring robust, GMP-qualified assays that can distinguish the therapeutic from any other in the facility. Liquid Chromatography-Mass Spectrometry (LC-MS) is a powerful analytical tool used to identify and characterize biologics. While routinely leveraged for characterization, LC-MS is relatively rare in Quality Control (QC) settings due to its perceived complexity and scarcity of MS-trained personnel. However, employing LC-MS for identification of drug products has many advantages versus conventional ID techniques, including but not limited to its high specificity, rapid turn-around time, and ease of method execution...
July 13, 2023: Journal of Pharmaceutical and Biomedical Analysis